Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-15 · accession 0001437749-23-015007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | 2023-05-15 | BLFS | Mathew Aby J. | EVP, CSO | S - Sale | $18.71 | -125 | 273.1K | -0.0% | -$2,339 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | S | D | 125 | $18.71 | 273,118 | D | — | — |